A recent study reported that the use of a c-Myc inhibitor, 10058-F4, significantly attenuated renal fibrosis in vivo, and in vitro experiments confirmed that c-Myc inhibitors and siRNA silencing of c-Myc blocked IL-1β-induced fibroblast proliferation and activation [10]. The gene discussed is IL1B; the disease is renal fibrosis.